Literature DB >> 23601740

[Risk factors associated with non-alcoholic fatty liver disease: a case-control study].

Llorenç Caballería1, Ingrid Arteaga, Guillem Pera, Lluís Rodríguez, Alba Alumà, Maria Antònia Auladell, Pere Torán.   

Abstract

BACKGROUND AND OBJECTIVES: To establish the factors associated with the presence of non-alcoholic fatty liver disease (NAFLD) and evaluate the influence of each component constituting the metabolic syndrome (MS) and the risk of developing NAFLD. PATIENTS AND METHODS: We performed a multicenter, population-based, observational, analytical study of cases and controls. A case was defined as any patient fulfilling the inclusion criteria and presenting NAFLD by abdominal echography for any reason. A control was randomly selected for each case, from the same health center and of the same age and sex. All the cases underwent anamnesis, physical examination, complete biochemical analyses and determination of MS according to the National Cholesterol Education Program-Adult Treatment Panel III criteria. All the controls also underwent an abdominal echography.
RESULTS: We included 327 cases and 377 controls with a mean age of 56 ± 12 years for the cases and of 55 ± 13 years for the controls (range: 17 and 80 years); 52.0% of the cases were males and 49.1% of males were controls. The risk factors associated with NAFLD were obesity (odds ratio [OR] 3.82, 95% confidence interval [95% CI] 2.19-6.66), MS (OR 1.73, 95% CI 1.09-2.75), insulin resistance (OR 3.65, 95% CI 2.18-6.12), and an increase in alanine aminotransferase (ALT) (OR 4.72, 95% CI 2.58-8.61) and gamma glutamyl transferase values (GGT) (OR 1.95, 95% CI 1.14-3.34). The components of the MS best predicting NAFLD were hyperglycemia (OR 1.65, 95% CI1.06-2.56) and triglyceride values (OR 1.75, 95% CI1.13-2.72).
CONCLUSIONS: The independent variables associated with NAFLD were obesity, insulin resistance and elevated ALT and GGT. The components of MS best predicting NAFLD were hyperglycemia and an increase in triglyceride values.
Copyright © 2012 Elsevier España, S.L. All rights reserved.

Entities:  

Keywords:  Abdominal echography; Diabetes; Ecografía abdominal; Hígado graso no alcohólico; Metabolic syndrome; Non-alcoholic fatty liver disease; Obesidad; Obesity; Síndrome metabólico

Mesh:

Substances:

Year:  2013        PMID: 23601740     DOI: 10.1016/j.medcli.2012.11.034

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  3 in total

1.  A 12-week, randomized, double-blind study to evaluate the efficacy and safety of liver function after using fermented ginseng powder (GBCK25).

Authors:  Su-Jin Jung; Ji-Hyun Hwang; Soo-Hyun Park; Eun-Kyung Choi; Ki-Chan Ha; Hyang-Im Baek; Dong-Gue Shin; Jeong-Hun Seo; Soo-Wan Chae
Journal:  Food Nutr Res       Date:  2020-04-06       Impact factor: 3.894

2.  Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Maria Nadinskaia; Marina Maevskaya; Vladimir Ivashkin; Khava Kodzoeva; Irina Pirogova; Evgeny Chesnokov; Alexander Nersesov; Jamilya Kaibullayeva; Akzhan Konysbekova; Aigul Raissova; Feruza Khamrabaeva; Elena Zueva
Journal:  World J Gastroenterol       Date:  2021-03-14       Impact factor: 5.742

3.  Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients.

Authors:  Isabel Belinchón-Romero; Pablo Bellot; David Romero-Pérez; Isolina Herraiz-Romero; Francisco Marco; Rubén Frances; José-Manuel Ramos-Rincón
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.